246 related articles for article (PubMed ID: 37958583)
21. Recent Trends in Advanced Contact Lenses.
Mutlu Z; Shams Es-Haghi S; Cakmak M
Adv Healthc Mater; 2019 May; 8(10):e1801390. PubMed ID: 30938941
[TBL] [Abstract][Full Text] [Related]
22. Polymeric Materials for Eye Surface and Intraocular Applications.
Karayilan M; Clamen L; Becker ML
Biomacromolecules; 2021 Feb; 22(2):223-261. PubMed ID: 33405900
[TBL] [Abstract][Full Text] [Related]
23. Applications of Hyaluronic Acid in Ophthalmology and Contact Lenses.
Chang WH; Liu PY; Lin MH; Lu CJ; Chou HY; Nian CY; Jiang YT; Hsu YH
Molecules; 2021 Apr; 26(9):. PubMed ID: 33923222
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
25. Patients' and prescribers' perception of contact lenses as a potential ocular drug delivery system.
Ghazal H; Ahmadouk J; Dhanji S; El-Bushra A; Kayyali R; ElShaer A
Cont Lens Anterior Eye; 2019 Apr; 42(2):190-195. PubMed ID: 30442512
[TBL] [Abstract][Full Text] [Related]
26. Review of the latest solutions in the use of contact lenses as controlled release systems for ophthalmic drugs.
Stiler-Wyszyńska S; Golba S; Jurek-Suliga J; Kuczkowski S
Polim Med; 2023; 53(1):47-58. PubMed ID: 36637332
[TBL] [Abstract][Full Text] [Related]
27. Sustained drug release by contact lenses for glaucoma treatment-a review.
Carvalho IM; Marques CS; Oliveira RS; Coelho PB; Costa PC; Ferreira DC
J Control Release; 2015 Mar; 202():76-82. PubMed ID: 25617723
[TBL] [Abstract][Full Text] [Related]
28. Ophthalmic gels: Past, present and future.
Al-Kinani AA; Zidan G; Elsaid N; Seyfoddin A; Alani AWG; Alany RG
Adv Drug Deliv Rev; 2018 Feb; 126():113-126. PubMed ID: 29288733
[TBL] [Abstract][Full Text] [Related]
29. Contact lenses as drug-delivery systems: a promising therapeutic tool.
Holgado MA; Anguiano-Domínguez A; Martín-Banderas L
Arch Soc Esp Oftalmol (Engl Ed); 2020 Jan; 95(1):24-33. PubMed ID: 31420118
[TBL] [Abstract][Full Text] [Related]
30. Contact lenses as drug reservoirs & delivery systems: the successes & challenges.
ElShaer A; Ghatora B; Mustafa S; Alany RG
Ther Deliv; 2014 Oct; 5(10):1085-100. PubMed ID: 25418268
[TBL] [Abstract][Full Text] [Related]
31. Inner layer-embedded contact lenses for pH-triggered controlled ocular drug delivery.
Zhu Q; Liu C; Sun Z; Zhang X; Liang N; Mao S
Eur J Pharm Biopharm; 2018 Jul; 128():220-229. PubMed ID: 29730260
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: Advances in extended and targeted drug delivery.
Abdi B; Mofidfar M; Hassanpour F; Kirbas Cilingir E; Kalajahi SK; Milani PH; Ghanbarzadeh M; Fadel D; Barnett M; Ta CN; Leblanc RM; Chauhan A; Abbasi F
Int J Pharm; 2023 May; 638():122740. PubMed ID: 36804524
[TBL] [Abstract][Full Text] [Related]
33. Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications.
Beg S; Rahman M; Jain A; Saini S; Midoux P; Pichon C; Ahmad FJ; Akhter S
Drug Discov Today; 2017 Apr; 22(4):625-637. PubMed ID: 27742533
[TBL] [Abstract][Full Text] [Related]
34. Advances and limitations of drug delivery systems formulated as eye drops.
Jumelle C; Gholizadeh S; Annabi N; Dana R
J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938
[TBL] [Abstract][Full Text] [Related]
35. Ocular Drug Delivery: Present Innovations and Future Challenges.
Gote V; Sikder S; Sicotte J; Pal D
J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
[TBL] [Abstract][Full Text] [Related]
36. Bovine serum albumin-meloxicam nanoaggregates laden contact lenses for ophthalmic drug delivery in treatment of postcataract endophthalmitis.
Zhang W; Zu D; Chen J; Peng J; Liu Y; Zhang H; Li S; Pan W
Int J Pharm; 2014 Nov; 475(1-2):25-34. PubMed ID: 25158220
[TBL] [Abstract][Full Text] [Related]
37. Emerging Trends in Nanomedicine for Improving Ocular Drug Delivery: Light-Responsive Nanoparticles, Mesoporous Silica Nanoparticles, and Contact Lenses.
Rodrigues FSC; Campos A; Martins J; Ambrósio AF; Campos EJ
ACS Biomater Sci Eng; 2020 Dec; 6(12):6587-6597. PubMed ID: 33320633
[TBL] [Abstract][Full Text] [Related]
38. A Meta-Analysis of Wearable Contact Lenses for Medical Applications: Role of Electrospun Fiber for Drug Delivery.
Hosseinian H; Hosseini S; Martinez-Chapa SO; Sher M
Polymers (Basel); 2022 Jan; 14(1):. PubMed ID: 35012207
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.
Gaballa SA; Kompella UB; Elgarhy O; Alqahtani AM; Pierscionek B; Alany RG; Abdelkader H
Drug Deliv Transl Res; 2021 Jun; 11(3):866-893. PubMed ID: 32901367
[TBL] [Abstract][Full Text] [Related]
40. Contact lenses in ocular therapeutics.
Gupta H; Aqil M
Drug Discov Today; 2012 May; 17(9-10):522-7. PubMed ID: 22305935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
